ResMed opens manufacturing centre in Singapore, expanding manufacturing footprint to support growth, development, and production of digital health solutions

• New 270,000-square-foot (25,000-square-meter) facility in Tuas marks the next stage in ResMed’s more than decade-long presence in Singapore; will account for nearly 1,000 jobs across a variety of skill sets, contributing to the country’s fast-growing local health technology sector
• The facility significantly increases ResMed’s production capacity of masks for its cloud-connected medical devices and serves as the primary production location for its newest AirSense 11 device
  

ResMed this week celebrated the grand opening of its new Advanced Manufacturing Centre in Tuas, Singapore.

The 270,000-square-foot (25,000-square-meter) facility more than doubles the size of ResMed’s footprint in Singapore and serves as ResMed’s key manufacturing hub in Asia-Pacific. The facility will account for nearly 1,000 jobs and features smart dashboards that integrates real-time data to monitor the performance of production lines.

The facility has the manufacturing capacity and footprint to scale production for connected devices and mask systems to help people sleep, breathe, and live better lives – particularly people worldwide with sleep apnea, a chronic disease affecting an estimated 936 million people worldwide – including nearly 2.3 million people in Singapore, according to Lancet Respiratory Medicine. ResMed’s AirSense 11, the company’s latest PAP (positive airway pressure) device that allows users to monitor their own sleep apnea treatment via the myAir app, will be produced in this facility.

ResMed has been operating in Singapore for over a decade, and will continue to grow regional teams across manufacturing, product development, operations, corporate, and commercial functions.

ResMed’s grand opening of its Advanced Manufacturing Centre was officiated by guest of honour and Singapore Senior Minister Tharman Shanmugaratnam, along with Australia’s High Commissioner to Singapore William Hodgman and U.S. Ambassador to Singapore Jonathan Kaplan.

For more information on ResMed, please visit http://www.resmed.sg.